Advertisement
Person › Details
Jörg Reinhardt (Novartis AG (NYSE: NVS))
Reinhardt, Jörg (Novartis 201308– Board Chairman before Bayer 201008– CEO Bayer HealthCare AG before Novartis COO)
Organisation | Novartis AG (NYSE: NVS) | |
Group | Novartis (Group) | |
Former/major organisation | Bayer HealthCare AG | |
Group | Bayer (Group) | |
Product | pharmaceutical | |
Record changed: 2022-08-27 |
Advertisement
More documents for Jörg Reinhardt
- [1] Novartis AG. (8/25/22). "Press Release: Novartis Announces Intention to Separate Sandoz Business to Create a Standalone Company by Way of a 100% Spin-off". Basel....
- [2] Novartis AG. (2/28/17). "Press Release: Novartis Shareholders Approve All Resolutions Proposed by Board of Directors at the Annual General Meeting". Basel....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top